Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease

Anatol J Cardiol. 2023 Jan;27(1):54-55. doi: 10.14744/AnatolJCardiol.2022.2333.
No abstract available

MeSH terms

  • Anticoagulants / therapeutic use
  • Atrial Fibrillation* / complications
  • Atrial Fibrillation* / drug therapy
  • Humans
  • Risk Factors
  • Stroke*

Substances

  • Anticoagulants